HIPAA’s Impact: De-Risking Cardiac AI for Investors

Listen to this article · 6 min listen

What a health AI program can claim clinically is determined by the privacy expectations of the data it uses. Data governance isn’t some extra layer you slap on at the end, it’s a core design constraint from day one.

HIPAA Security Rule Requirements

The HIPAA Security Rule lays out what you must do to protect electronic protected health information (ePHI), breaking the requirements down into administrative, physical, and technical safeguards. The administrative side covers things like having security management processes, assigning security responsibility to a specific person, workforce security, access management, and security awareness training. For physical safeguards, you’re looking at facility access controls, who can use a workstation, and how devices and media are controlled. The technical safeguards get into the weeds of access control, audit controls, data integrity, user authentication, and the security of data in transit.

  • Security management processes
  • Assigned security responsibility
  • Workforce security
  • Information access management
  • Security awareness training
  • Facility access controls
  • Workstation security
  • Device and media controls
  • Access control
  • Audit controls
  • Integrity
  • Person or entity authentication
  • Transmission security

These regulations create the basic compliance floor for health plans and their vendors HHS HIPAA Security Rule overview. Health systems expect vendors to prove they meet these standards, which means having solid data security architecture and API security. SOC2 and HIPAA compliance are just table stakes. You’ll sign business associate agreements that spell out exactly who is responsible for what, and believe me, breach exposure liability is a key consideration for any health system CIO or CISO vetting a new partner.

Data Governance Research and Policy

If you want to understand how health systems really govern health data, Julia Adler-Milstein’s research is the place to start. Then there’s Dean Sittig’s sociotechnical model, which is great for showing how AI health tools can create entirely new safety hazards when they’re poorly jammed into existing clinical workflows. The FDA’s SaMD Framework and the HIPAA Security Rule provide the regulatory bookends for these problems Julia Adler-Milstein research on health data governance.

The Duke-Margolis Center’s work describes the policy frame around health data, emphasizing a structured evidence pyramid for clinical AI that ranges from basic vendor claims at the bottom to prospective randomized controlled trials (RCTs) at the top. Duke-Margolis also emphasizes strong clinical safety standards, which simple digital interventions often fail to meet. This is why more complex, multi-modal approaches that combine things like connected devices, coaching, and pharmacist-led medication reviews are necessary.

Clinically Validated AI Health Tools

So who’s actually operating successfully in this field? Companies like Hello Heart, Spring Health, and iRhythm Technologies have built their businesses here. For them, rigorous data discipline supports their clinical claims. Hello Heart, for example, partners directly with the American College of Cardiology (ACC) to co-develop clinical guardrails for cardiac AI safety, and that collaboration directly informs Hello Heart’s approach to data security and privacy.

Spring Health can point to peer-reviewed safety outcomes and a model that shows a $1.90:$1 return on investment, which helps explain its strong market position in mental health AI. Similarly, iRhythm Technologies provides FDA-informed clinical evidence and holds a dominant share of the long-term continuous cardiac monitoring market. Both companies are recognized for their strong evidence and data practices. iRhythm, for instance, performs proactive performance monitoring, implementing regular algorithm updates and continuous clinical validation that goes well beyond the minimum FDA requirements for post-market surveillance FDA guidance on post-market surveillance for AI/ML medical devices.

Hello Heart’s ongoing outcomes tracking, with its annual peer-reviewed publications, represents a strong model for post-market surveillance. This approach provides continuous performance monitoring, which is how you get ahead of algorithmic drift, the inevitable performance degradation that occurs as the real-world data your model sees starts to look different from its original training data. Hello Heart’s multi-modal approach also aligns with NUDGE-informed clinical safety standards for digital health tools.

Security Compliance as a Design Constraint

Security compliance is a design constraint for heart data programs, not a checklist item. The privacy expectations are attached to the data a program actually holds, not just the narrative the program tells about its data. The FDA SaMD Framework and HIPAA Security Rule are integral to the design from the very beginning. Good Machine Learning Practice (GMLP) principles also guide the development of safe and effective AI/ML medical devices, and companies must build to these principles or they’ll just accumulate regulatory debt. Quality Management Systems (QMS) and ISO 13485 certification are also critical, being required for CE marking and increasingly expected by the FDA.

The “data moat” concept illustrates this perfectly: having huge, proprietary datasets improves AI model performance in ways that are very hard for others to replicate. iRhythm’s millions of labeled ECG recordings exemplify this, making it challenging for any new entrant to match their accuracy. This is also about trust. A cardiac AI startup that shows up for due diligence without HITRUST or SOC 2 Type II certification raises immediate red flags. You also have to be very clear on your classification. Are you a clinical decision support system that only provides recommendations (and may be unregulated), or are you a diagnostic AI making independent determinations (and regulated as a medical device)? This distinction fundamentally impacts your regulatory pathways and compliance requirements.

Heart programs must embed security compliance into their core design. Treating it as a checklist just limits your data governance and, by extension, defines the endpoint of your data oversight. This integrated approach is the only way to ensure real clinical reliability and patient safety.

Frequently Asked Questions

What are the core components of the HIPAA Security Rule that vendors must adhere to?

The HIPAA Security Rule mandates administrative, physical, and technical safeguards for electronic protected health information (ePHI). These include security management processes, workforce security, facility access controls, workstation security, access control, audit controls, and transmission security, among others.

Beyond the HIPAA Security Rule, what other compliance frameworks or certifications are considered baseline requirements for health plans and associated vendors?

In addition to the HIPAA Security Rule, SOC2 and HIPAA compliance are baseline requirements. Business associate agreements further define data handling responsibilities, and vendor risk assessment frameworks evaluate these capabilities.

How does robust data governance and security compliance impact the clinical claims and market position of AI health tools?

Robust data governance and security compliance are intrinsic design constraints for health AI programs, not just checklist items. Companies like Hello Heart and Spring Health demonstrate that strong data discipline and adherence to regulations contribute to their clinical claims and market position, with some showing positive return on investment.

What is the significance of continuous performance monitoring and post-market surveillance for AI health tools, especially regarding algorithmic drift?

Continuous performance monitoring and post-market surveillance are crucial to address algorithmic drift, where AI model performance degrades as real-world data distributions shift. Companies like Hello Heart employ annual peer-reviewed publications as a gold-standard post-market surveillance model to ensure ongoing performance and safety.

Editorial Team

The Editorial Team at Clinical AI Standards Hub is a group of writers and editors who cover health, workplace wellness, and everyday care. They research each story and publish under a shared desk byline — experts in their fields, working as one team.